HK33691A - Medical composition for external application - Google Patents
Medical composition for external applicationInfo
- Publication number
- HK33691A HK33691A HK336/91A HK33691A HK33691A HK 33691 A HK33691 A HK 33691A HK 336/91 A HK336/91 A HK 336/91A HK 33691 A HK33691 A HK 33691A HK 33691 A HK33691 A HK 33691A
- Authority
- HK
- Hong Kong
- Prior art keywords
- external application
- medical composition
- medical
- composition
- external
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59213152A JPS6191137A (ja) | 1984-10-11 | 1984-10-11 | 外用薬剤組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK33691A true HK33691A (en) | 1991-05-10 |
Family
ID=16634426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK336/91A HK33691A (en) | 1984-10-11 | 1991-05-02 | Medical composition for external application |
Country Status (7)
Country | Link |
---|---|
US (1) | US4686211A (xx) |
EP (1) | EP0179277B1 (xx) |
JP (1) | JPS6191137A (xx) |
DE (1) | DE3565937D1 (xx) |
ES (1) | ES8701683A1 (xx) |
HK (1) | HK33691A (xx) |
MY (1) | MY100022A (xx) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01151516A (ja) * | 1987-12-08 | 1989-06-14 | Shionogi & Co Ltd | ビタミンe配合外用剤 |
GB8828013D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
GB8828018D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
GB8828017D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
GB8828014D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
GB8828020D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
US4906454A (en) * | 1989-02-23 | 1990-03-06 | The Procter & Gamble Company | Deodorant compositions containing specific piroctone salts and perfumes |
US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
GB9003199D0 (en) * | 1990-02-13 | 1990-04-11 | Unilever Plc | Topical composition |
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
GB9101986D0 (en) * | 1991-01-30 | 1991-03-13 | Smith & Nephew | Pharmaceutical compositions |
US5409911A (en) * | 1992-09-11 | 1995-04-25 | Merck & Co., Inc. | Prostaglandin analog for treating osteoporosis |
TW251302B (xx) * | 1992-12-28 | 1995-07-11 | Kao Corp | |
US5665742A (en) * | 1994-05-31 | 1997-09-09 | Kao Corporation | Bath medicine composition and its use in inhibiting the generation of body odor |
US6239172B1 (en) * | 1997-04-10 | 2001-05-29 | Nitrosystems, Inc. | Formulations for treating disease and methods of using same |
US5543430A (en) * | 1994-10-05 | 1996-08-06 | Kaesemeyer; W. H. | Method and formulation of stimulating nitric oxide synthesis |
US20110196039A9 (en) * | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
US5968983A (en) * | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
US5560913A (en) * | 1995-01-27 | 1996-10-01 | The Procter & Gamble Company | Pharmaceutical compositions |
US6605751B1 (en) * | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
WO1999039575A2 (en) * | 1998-02-09 | 1999-08-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Synergistic biocidal activity of ternary complexes of negatively -charged biocides (component a), transition metal ions (component b), and neutral chelators (component c) |
US5972920A (en) * | 1998-02-12 | 1999-10-26 | Dermalogix Partners, Inc. | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
US6121253A (en) * | 1998-11-20 | 2000-09-19 | Merck Frosst Canada & Co. | Prostaglandin conjugates for treating or preventing bone disease |
US6254294B1 (en) * | 1999-08-09 | 2001-07-03 | Sigrid G. Muhar | Pharmaceutical kit |
FR2799369B1 (fr) * | 1999-10-08 | 2001-12-21 | Oreal | Association d'escine et de sulfate de dextran et son utilisation |
ATE327779T1 (de) | 1999-12-30 | 2006-06-15 | Acrymed | Methode und zusammensetzungen für verbesserte abgabevorrichtungen |
US7758888B2 (en) * | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
JP2004513183A (ja) * | 2000-11-14 | 2004-04-30 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | リン酸誘導体の複合体 |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
EP1254909A1 (de) * | 2001-04-30 | 2002-11-06 | Cognis Iberia, S.L. | Phosphorsäureester |
JP4745608B2 (ja) * | 2001-07-27 | 2011-08-10 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 電子伝達剤のリン酸誘導体を用いた皮膚治療 |
AU2002350272B1 (en) * | 2001-12-13 | 2003-06-23 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
US6833139B1 (en) * | 2002-01-09 | 2004-12-21 | Ferndale Laboratories, Inc. | Composition and method for the treatment of anorectal disorders |
CN1678277B (zh) * | 2002-07-29 | 2010-05-05 | 艾克里麦德公司 | 治疗皮肤病的方法和组合物 |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
JP4690305B2 (ja) * | 2003-01-17 | 2011-06-01 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗増殖性質を有する化合物 |
AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
WO2005084678A1 (en) * | 2004-03-03 | 2005-09-15 | Vital Health Sciences Pty Ltd | Alkaloid formulations |
US20050282870A1 (en) * | 2004-06-16 | 2005-12-22 | Carter Stephen G | Peripherally-acting vasodilators |
NZ592438A (en) | 2004-07-30 | 2012-11-30 | Kimberly Clark Co | Antimicrobial compositions of silver nanoparticles |
EP1781098B1 (en) * | 2004-07-30 | 2015-10-07 | Avent, Inc. | Antimicrobial devices and compositions |
US8361553B2 (en) | 2004-07-30 | 2013-01-29 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for metal nanoparticle treated surfaces |
EP1809264B1 (en) * | 2004-09-20 | 2016-04-13 | Avent, Inc. | Antimicrobial amorphous compositions |
EP1858508A4 (en) * | 2005-03-03 | 2009-01-07 | Vital Health Sciences Pty Ltd | COMPOUNDS HAVING ANTICANCER PROPERTIES |
CA2611831C (en) * | 2005-06-17 | 2014-09-16 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
JP5164840B2 (ja) * | 2005-08-02 | 2013-03-21 | ソル − ゲル テクノロジーズ リミテッド | 水不溶性成分の金属酸化物被覆 |
EP1973547A1 (en) * | 2005-12-23 | 2008-10-01 | Vital Health Sciences Pty Ltd. | Compounds having cytokine modulating properties |
US8293965B2 (en) * | 2006-04-28 | 2012-10-23 | Kimberly-Clark Worldwide, Inc. | Antimicrobial site dressings |
CA2677185C (en) * | 2007-02-01 | 2013-12-03 | Ofer Toledano | Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
EA200970724A1 (ru) | 2007-02-01 | 2010-02-26 | Сол-Джел Текнолоджиз Лтд. | Композиции для местного применения, содержащие пероксид и ретиноид |
AU2009316270B2 (en) * | 2008-11-24 | 2015-08-27 | Avent, Inc. | Antimicrobial laminate constructs |
JP2010235523A (ja) * | 2009-03-31 | 2010-10-21 | Kao Corp | 水性毛髪洗浄剤 |
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
US9687465B2 (en) | 2012-11-27 | 2017-06-27 | Sol-Gel Technologies Ltd. | Compositions for the treatment of rosacea |
AU2016367708B2 (en) | 2015-12-09 | 2022-07-14 | Phosphagenics Limited | Pharmaceutical formulation |
MX2019006845A (es) | 2016-12-21 | 2019-10-15 | Avecho Biotechnology Ltd | Proceso. |
JP2019043853A (ja) * | 2017-08-30 | 2019-03-22 | 旭化成株式会社 | 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4046886A (en) * | 1975-01-17 | 1977-09-06 | The Procter & Gamble Company | Dermatological compositions |
US4130667A (en) * | 1976-01-12 | 1978-12-19 | The Procter & Gamble Company | Dermatological compositions |
-
1984
- 1984-10-11 JP JP59213152A patent/JPS6191137A/ja active Granted
-
1985
- 1985-09-19 EP EP85111872A patent/EP0179277B1/en not_active Expired
- 1985-09-19 DE DE8585111872T patent/DE3565937D1/de not_active Expired
- 1985-09-20 US US06/778,226 patent/US4686211A/en not_active Expired - Fee Related
- 1985-10-09 ES ES547738A patent/ES8701683A1/es not_active Expired
-
1987
- 1987-03-26 MY MYPI87000383A patent/MY100022A/en unknown
-
1991
- 1991-05-02 HK HK336/91A patent/HK33691A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3565937D1 (en) | 1988-12-08 |
US4686211A (en) | 1987-08-11 |
ES547738A0 (es) | 1986-12-01 |
EP0179277A1 (en) | 1986-04-30 |
MY100022A (en) | 1989-04-20 |
JPH0469129B2 (xx) | 1992-11-05 |
ES8701683A1 (es) | 1986-12-01 |
JPS6191137A (ja) | 1986-05-09 |
EP0179277B1 (en) | 1988-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3565937D1 (en) | Medical composition for external application | |
EP0173990A3 (en) | External pharmaceutical composition | |
GB2167299B (en) | Dental caries-preventive composition | |
GB2153678B (en) | Pharmaceutical composition | |
HUT40335A (en) | Disinfecting composition | |
ZA853823B (en) | Pharmaceutical composition | |
GB8426152D0 (en) | Medicinal compositions | |
GB2160771B (en) | Composition for oral application | |
DE3567374D1 (en) | Composition for ophthalmological use | |
GB2153677B (en) | Pharmaceutical composition | |
GB8513641D0 (en) | Pharmaceutical composition | |
GB8523491D0 (en) | Medicinal composition | |
GB2158714B (en) | Composition | |
GB2153676B (en) | Pharmaceutical composition | |
GB8419245D0 (en) | Medicinal compositions | |
GB8518565D0 (en) | Pharmaceutical composition | |
EP0321786A3 (en) | Composition for external application | |
GB2199774B (en) | Application for crease-setting composition | |
GB8414713D0 (en) | Disinfectant composition | |
GB8419747D0 (en) | Disinfectant composition | |
IE841175L (en) | Pharmaceutical composition | |
GB8513640D0 (en) | Pharmaceutical composition | |
GB8424514D0 (en) | Pharmaceutical composition | |
GB8421779D0 (en) | Pharmaceutical composition | |
GB8424513D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |